Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999)

Journal of the American Veterinary Medical Association

Volumn 218, Issue 9, 2001, Pages 1449-1455

  Logan, Jaime C ^a   Callan, Mary Beth ^a   Drew, Krista ^a   Marryott, Kym ^a   Oakley, Donna A ^a   Jefferies, Leigh ^a   Giger, Urs ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; ILEX COOKII;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BODY WEIGHT; CRITICAL ILLNESS; DOG; DOG DISEASE; FEMALE; MALE; PLASMA; RETROSPECTIVE STUDY;

ANIMALS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; BODY WEIGHT; CRITICAL ILLNESS; DOG DISEASES; DOGS; FEMALE; MALE; PLASMA; RETROSPECTIVE STUDIES;

EID: 0035346920     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.218.1449     Document Type: Article

References (32)

1. Silberstein LE, Kruskall MS, Stehling LC, et al. Strategies for the review of transfusion practices. JAMA 1989;262:1993-1997.
2. Vengelen-Tyler V, Brecher ME, Butch AH, et al, eds. Technical manual. Bethesda, Md: American Association of Blood Banks, 1999.
3. Consensus Development Panel, National Institutes of Health. Fresh frozen plasma. Indications and risks. JAMA 1985;253:551-553.
4. College of American Pathologists. Practice parameters for the use of fresh frozen plasma, cryoprecipitate and platelets. JAMA 1994;271:777-778.
5. Cotter SM. Clinical transfusion medicine. In: Comparative transfusion medicine. New York: Academic Press Inc, 1991;187-223.
6. Hoeltge GA, Brown JC, Herzig RH, et al. Computer-assisted audits of blood component transfusion. Clev Clin J Med 1989;56:267-272.
7. Penn Animal Blood Bank. Standard operating procedures. Philadelphia: Penn Animal Blood Bank, 1999.
8. Rossi EC, Simon TL, Gerald SM. Principles of transfusion medicine. Baltimore: The Williams & Wilkins Co, 1991.
9. Hospital of the University of Pennsylvania. Physician practice guidelines. No. 1-7-17. Philadelphia: Hospital of the University of Pennsylvania, 1999.
10. Knowler C, Giger U, Dodds WJ, et al. Factor XI deficiency in Kerry Blue Terriers. J Am Vet Med Assoc 1994;205:1557-1561.
11. Stokol T, Parry BW. Efficacy of fresh frozen plasma and cryoprecipitate in dogs with von Willebrand's disease or hemophilia A. J Vet Intern Med 1998;12:84-92.
12. Feldman DG, Brooks MB, Dodds WJ. Hemophilia B (factor IX deficiency) in a family of German Shepherd Dogs. J Am Vet Med Assoc 1995;206:1901-1905.
13. Mount ME, Feldman BF. Buffington T. Vitamin K and its therapeutic importance. J Am Vet Med Assoc 1982;180:1354-1356.
14. Rozanski EA, Hughes D, Giger U. The effect of heparin and fresh frozen plasma on plasma antithrombin III activity, prothrombin time and activated partial thromboplastin time in critically ill dogs. J Vet Emerg Crit Care 2001;11:15-21.
15. Tseng LW, Hughes D, and Giger U. Clinical evaluation of a point-of-care instrument. Am J Vet Res 2001;62:in press.
16. Murray D, Pennell B, Olson J. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion 1999;39:56-62.
17. Mathews KA. The various types of parenteral fluids and their indications. Vet Clin North Am Small Anim Pract 1998;28:483-513.
18. Hospital of the University of Pennsylvania. Practice guideline: use of albumin, nonprotein colloid, and crystalloid solutions. No. 1-9-06. Philadelphia: Hospital of the University of Pennsylvania, 1996.
19. Foley EF, Borlase BC, Dzik WH, et al. Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg 1990;125:739-742.
20. Moore LE. Fluid therapy in the hypoproteinemic patient. Vet Clin North Am Small Anim Pract 1998;28:709-715.
21. Griffel Ml, Kaufman BS. Fluid resuscitation of the critically ill: pharmacology of colloids and crystalloids. Crit Care Clin 1992;8:235-253.
22. Kaminski MV, Hasse TJ. Albumin and colloid osmotic pressure: implications for fluid resuscitation. Crit Care Clin 1992;8: 311-321.
23. Leese T, West KP, Morton DB, et al. Fresh frozen plasma therapy in acute pancreatitis: an experimental study. Int J Pancreatol 1988;3:437-447.
24. Wilson C, Imrie CW. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats. Br J Surg 1990; 77:1252-1255.
25. Murtaugh RJ, Jacobs RM. Serum antiprotease concentrations in dogs with spontaneous and experimentally induced acute pancreatitis. Am J Vet Res 1985;46:80-83.
26. Williams DA. Diagnosis and management of pancreatitis. J Small Anim Pract 1994;35:445-454.
27. Kimura W, Meyer F, Hess D, et al. Comparison of different treatment modalities in experimental pancreatitis in rats. Gastroenterology 1992;103:1916-1924.
28. Leese T, Holliday M, Heath D, et al. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987;74:907-911.
29. Leese T, Holliday M, Watkins M, et al. A multicentre clinical trial of high volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl 1991;73:207-214.
30. Wessels BC, Gaffin SL. Anti-endotoxin immunotherapy for canine parvovirus endotoxaemia. J Small Anim Pract 1986;27:609-615.
31. Acunas BA, Peakinan M, Liossis G, et al. Effect of fresh frozen plasma and gamma globulin on humoral immunity in neonatal sepsis. Arch Dis Child 1994;70:F182-F187.
32. Scott-Moncrieff JCR, Reagan WJ, Snyder PW, et al. Intravenous administration of human immune globulin in clogs with immune-mediated hemolytic anemia. J Am Vet Med Assoc 1997;210: 1623-1627.